Sponsors (3)
Introduced April 17, 2025 by David Joyce · Last progress April 17, 2025
The bill shifts federal policy toward a regulated system that expands medical and consumer access and reduces criminal penalties, while trading off new regulatory and administrative costs, transitional legal complexity, and risks that enforcement inequities and public-safety concerns may persist.
People with qualifying medical conditions (patients with chronic conditions) would gain clearer federal access to medical cannabis and researchers would face fewer federal barriers, improving treatment options and enabling better safety and impairment research.
Consumers (including families and youth advocates) would get a federal regulatory framework (labeling, age limits, licensing) that brings more consistent product safety, oversight, and youth protections across states.
People convicted of federal marijuana offenses (disproportionately low-income people and racial and ethnic minorities) could regain rights and avoid ongoing collateral consequences if prohibition ends and the law promotes expungement or remedial measures.
Vulnerable communities (racial and ethnic minorities, low-income people, immigrants) may not receive timely or sufficient remedies for past enforcement harms and could face increased federal enforcement in states that currently restrict cannabis.
Parents, transportation workers, and other public-safety stakeholders could see higher adult cannabis availability, raising public-health and impairment risks (driving, workplace safety).
Taxpayers and state governments would likely bear increased administrative and implementation costs to create and run new federal and state regulatory programs and commissions.
Based on analysis of 4 sections of legislative text.
Creates a federal Commission to study and recommend a prompt pathway to federal cannabis regulation covering criminal justice, banking, research, safety, commerce, and hemp coexistence.
Creates a federal commission charged with developing a plausible, prompt pathway to end federal marijuana prohibition and to design a federal regulatory framework modeled in part on alcohol regulation. The commission must study criminalization impacts, banking access, research barriers, product safety and labeling, interstate and international commerce, hemp/cannabis coexistence, and other obstacles; hold public hearings and solicit comments; and deliver an initial report within 120 days and final recommendations within one year. The Attorney General must establish the Commission within 30 days of enactment; the Commission must solicit public comment within 60 days, convene witness hearings and take testimony within 180 days, and include specific stakeholder representation (single- and multi-state operators, individuals convicted of cannabis offenses, among others). The Commission’s work is intended to prepare the federal government—Executive and Congress—for a prompt end to federal marijuana prohibition and the transition to a regulated adult-use market while addressing equity, safety, and trade issues.